Appleton Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $805K | Buy |
1,808
+15
| +0.8% | +$6.68K | 0.06% | 147 |
|
|
2025
Q1 | $869K | Sell |
1,793
-15
| -0.8% | -$7.27K | 0.07% | 135 |
|
|
2024
Q4 | $728K | Buy |
1,808
+4
| +0.2% | +$1.61K | 0.05% | 147 |
|
|
2024
Q3 | $839K | Hold |
1,804
| – | – | 0.06% | 141 |
|
|
2024
Q2 | $846K | Sell |
1,804
-42
| -2% | -$19.7K | 0.07% | 141 |
|
|
2024
Q1 | $772K | Sell |
1,846
-219
| -11% | -$91.6K | 0.06% | 151 |
|
|
2023
Q4 | $840K | Sell |
2,065
-1,196
| -37% | -$487K | 0.07% | 148 |
|
|
2023
Q3 | $1.13M | Sell |
3,261
-349
| -10% | -$121K | 0.1% | 126 |
|
|
2023
Q2 | $1.27M | Sell |
3,610
-186
| -5% | -$65.4K | 0.11% | 131 |
|
|
2023
Q1 | $1.2M | Sell |
3,796
-1,287
| -25% | -$405K | 0.11% | 140 |
|
|
2022
Q4 | $1.47M | Sell |
5,083
-477
| -9% | -$138K | 0.14% | 130 |
|
|
2022
Q3 | $1.61M | Sell |
5,560
-242
| -4% | -$70.1K | 0.16% | 121 |
|
|
2022
Q2 | $1.64M | Sell |
5,802
-405
| -7% | -$114K | 0.15% | 121 |
|
|
2022
Q1 | $1.62M | Sell |
6,207
-925
| -13% | -$241K | 0.13% | 133 |
|
|
2021
Q4 | $1.57M | Sell |
7,132
-1,500
| -17% | -$329K | 0.12% | 139 |
|
|
2021
Q3 | $1.57M | Sell |
8,632
-825
| -9% | -$150K | 0.13% | 133 |
|
|
2021
Q2 | $1.91M | Sell |
9,457
-1,120
| -11% | -$226K | 0.16% | 120 |
|
|
2021
Q1 | $2.27M | Sell |
10,577
-451
| -4% | -$96.9K | 0.21% | 107 |
|
|
2020
Q4 | $2.61M | Buy |
11,028
+291
| +3% | +$68.8K | 0.26% | 86 |
|
|
2020
Q3 | $2.92M | Buy |
10,737
+822
| +8% | +$224K | 0.32% | 77 |
|
|
2020
Q2 | $2.88M | Buy |
9,915
+628
| +7% | +$182K | 0.34% | 77 |
|
|
2020
Q1 | $2.21M | Sell |
9,287
-55
| -0.6% | -$13.1K | 0.31% | 81 |
|
|
2019
Q4 | $2.05M | Buy |
9,342
+807
| +9% | +$177K | 0.22% | 107 |
|
|
2019
Q3 | $1.45M | Buy |
+8,535
| New | +$1.45M | 0.17% | 121 |
|